ReP USP - Resultado da busca

Artigo de periodico
Chronic treatment with fluoxetine modulates vascular adrenergic responses by inhibition of pre- and post synaptic mechanisms (2017)
Pereira, Camila A.; Rodrigues, Fernanda L.; Ruginsk, Silvia G.; Zanotto, Camila Z.; Rodrigues, José Antunes; Duarte, Diego A.; Costa Neto, Cláudio Miguel; Resstel, Leonardo Barbosa Moraes; Carneiro, Fernando Silva; Passaglia, Rita de Cássia Aleixo Tostes
Fonte: European Journal of Pharmacology. Unidade: FMRP
Assuntos: CÁLCIO, NOREPINEFRINA, RECEPTORES ADRENÉRGICOS, SISTEMA NERVOSO SIMPÁTICO, ESTIMULAÇÃO ELÉTRICA, FREQUÊNCIA CARDÍACA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Camila A. et al. Chronic treatment with fluoxetine modulates vascular adrenergic responses by inhibition of pre- and post synaptic mechanisms. European Journal of Pharmacology, v. 800, p. 70-80, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2017.02.029. Acesso em: 07 jul. 2024.
APA
Pereira, C. A., Rodrigues, F. L., Ruginsk, S. G., Zanotto, C. Z., Rodrigues, J. A., Duarte, D. A., et al. (2017). Chronic treatment with fluoxetine modulates vascular adrenergic responses by inhibition of pre- and post synaptic mechanisms. European Journal of Pharmacology, 800, 70-80. doi:10.1016/j.ejphar.2017.02.029
NLM
Pereira CA, Rodrigues FL, Ruginsk SG, Zanotto CZ, Rodrigues JA, Duarte DA, Costa Neto CM, Resstel LBM, Carneiro FS, Passaglia R de CAT. Chronic treatment with fluoxetine modulates vascular adrenergic responses by inhibition of pre- and post synaptic mechanisms [Internet]. European Journal of Pharmacology. 2017 ; 800 70-80.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1016/j.ejphar.2017.02.029
Vancouver
Pereira CA, Rodrigues FL, Ruginsk SG, Zanotto CZ, Rodrigues JA, Duarte DA, Costa Neto CM, Resstel LBM, Carneiro FS, Passaglia R de CAT. Chronic treatment with fluoxetine modulates vascular adrenergic responses by inhibition of pre- and post synaptic mechanisms [Internet]. European Journal of Pharmacology. 2017 ; 800 70-80.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1016/j.ejphar.2017.02.029
Artigo de periodico
Angeli's Salt, a nitroxyl anion donor, reverses endothelin-1 mediated vascular dysfunction in murine aorta (2017)
Wynne, Brandi M.; Labazi, Hicham; Carneiro, Zidonia N.; Tostes, Rita de Cássia Aleixo; Webb, R. Clinton
Fonte: European Journal of Pharmacology. Unidade: FMRP
Assuntos: AORTA, ENDOTELINAS, DOENÇAS VASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WYNNE, Brandi M. et al. Angeli's Salt, a nitroxyl anion donor, reverses endothelin-1 mediated vascular dysfunction in murine aorta. European Journal of Pharmacology, v. 814, p. 294-301, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2017.08.024. Acesso em: 07 jul. 2024.
APA
Wynne, B. M., Labazi, H., Carneiro, Z. N., Tostes, R. de C. A., & Webb, R. C. (2017). Angeli's Salt, a nitroxyl anion donor, reverses endothelin-1 mediated vascular dysfunction in murine aorta. European Journal of Pharmacology, 814, 294-301. doi:10.1016/j.ejphar.2017.08.024
NLM
Wynne BM, Labazi H, Carneiro ZN, Tostes R de CA, Webb RC. Angeli's Salt, a nitroxyl anion donor, reverses endothelin-1 mediated vascular dysfunction in murine aorta [Internet]. European Journal of Pharmacology. 2017 ; 814 294-301.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1016/j.ejphar.2017.08.024
Vancouver
Wynne BM, Labazi H, Carneiro ZN, Tostes R de CA, Webb RC. Angeli's Salt, a nitroxyl anion donor, reverses endothelin-1 mediated vascular dysfunction in murine aorta [Internet]. European Journal of Pharmacology. 2017 ; 814 294-301.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1016/j.ejphar.2017.08.024
Artigo de periodico
Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries (2015)
Pereira, Camila A.; Ferreira, Nathanne dos Santos; Mestriner, Fabíola Leslie Antunes Cardoso; Antunes-Rodrigues, José; Évora, Paulo Roberto Barbosa; Resstel, Leonardo Barbosa Moraes; Carneiro, Fernando Silva; Passaglia, Rita de Cassia Aleixo Tostes
Fonte: European Journal of Pharmacology. Unidade: FMRP
Assuntos: ANTIDEPRESSIVOS, ÓXIDO NÍTRICO, CANAIS IÔNICOS, POTÁSSIO, VASODILATAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Camila A. et al. Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries. European Journal of Pharmacology, v. 765, p. 375–383, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2015.09.002. Acesso em: 07 jul. 2024.
APA
Pereira, C. A., Ferreira, N. dos S., Mestriner, F. L. A. C., Antunes-Rodrigues, J., Évora, P. R. B., Resstel, L. B. M., et al. (2015). Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries. European Journal of Pharmacology, 765, 375–383. doi:10.1016/j.ejphar.2015.09.002
NLM
Pereira CA, Ferreira N dos S, Mestriner FLAC, Antunes-Rodrigues J, Évora PRB, Resstel LBM, Carneiro FS, Passaglia R de CAT. Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries [Internet]. European Journal of Pharmacology. 2015 ; 765 375–383.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1016/j.ejphar.2015.09.002
Vancouver
Pereira CA, Ferreira N dos S, Mestriner FLAC, Antunes-Rodrigues J, Évora PRB, Resstel LBM, Carneiro FS, Passaglia R de CAT. Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries [Internet]. European Journal of Pharmacology. 2015 ; 765 375–383.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1016/j.ejphar.2015.09.002
Artigo de periodico
Hydralazine reduces leukocyte migration through different mechanisms in spontaneously hypertensive and normotensive rats (2008)
Rodrigues, Stephen Fernandes de Paula ; Oliveira, Maria Aparecida de; Santos, Rosangela A. dos; Soares, Antonio G.; Passaglia, Rita de Cássia Aleixo Tostes; Carvalho, Maria Helena Catelli de; Fortes, Zuleica Bruno
Fonte: European Journal of Pharmacology. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Stephen Fernandes de Paula et al. Hydralazine reduces leukocyte migration through different mechanisms in spontaneously hypertensive and normotensive rats. European Journal of Pharmacology, v. 589, n. 1/3, p. 206-214, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.05.003. Acesso em: 07 jul. 2024.
APA
Rodrigues, S. F. de P., Oliveira, M. A. de, Santos, R. A. dos, Soares, A. G., Passaglia, R. de C. A. T., Carvalho, M. H. C. de, & Fortes, Z. B. (2008). Hydralazine reduces leukocyte migration through different mechanisms in spontaneously hypertensive and normotensive rats. European Journal of Pharmacology, 589( 1/3), 206-214. doi:10.1016/j.ejphar.2008.05.003
NLM
Rodrigues SF de P, Oliveira MA de, Santos RA dos, Soares AG, Passaglia R de CAT, Carvalho MHC de, Fortes ZB. Hydralazine reduces leukocyte migration through different mechanisms in spontaneously hypertensive and normotensive rats [Internet]. European Journal of Pharmacology. 2008 ; 589( 1/3): 206-214.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1016/j.ejphar.2008.05.003
Vancouver
Rodrigues SF de P, Oliveira MA de, Santos RA dos, Soares AG, Passaglia R de CAT, Carvalho MHC de, Fortes ZB. Hydralazine reduces leukocyte migration through different mechanisms in spontaneously hypertensive and normotensive rats [Internet]. European Journal of Pharmacology. 2008 ; 589( 1/3): 206-214.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1016/j.ejphar.2008.05.003

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Indexado em